- Supported exchanges /
- AU /
- MAP.AU
Microba Life Sciences Ltd (MAP AU) stock market data APIs
Microba Life Sciences Limited provides microbiome testing, supplements, and analysis services in Australia, Europe, New Zealand, the United Arab Emirates, the United Kingdom, the United States, Asia, and Ireland. It operates through two segments, Testing Services and Supplements, and Research and Development. The company also develops pathology, therapeutics, and diagnostics services based on the human gut microbiome. In addition, it offers MetaPanel, a metagenomic test for pathogen detection; MetaXplore, a diagnostics under the brand Co-Biome and MetaXplore; non-diagnostic personal and research testing services; and data-driven therapeutics platform that develops therapies for ulcerative colitis, inflammatory bowel disease, and autoimmune diseases, as well as microbiome databank. Microba Life Sciences Limited was incorporated in 2017 and is based in Brisbane, Australia.
Microba Life Sciences Ltd Financial Data Overview
0.1725 | |
0.17 | |
- | |
0.1725 | |
0.17 | |
0.145-0.37 | |
77 031 K | |
448 M | |
12 090 K | |
0 | |
2.808 |
No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.
Microba Life Sciences Ltd Fundamental Data is available in our Financial Data APIs
- Net Revenue 12 090 K
- EBITDA -24 610 016
- Earnings Per Share -0.05
- Income Statements
- Balance Sheets
- Cash flows
of Fundamental API Data
Get Microba Life Sciences Ltd Earnings via APIs
- Latest Release 2024-04-18
- EPS/Forecast 0
Get Microba Life Sciences Ltd End-of-day Data via APIs
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Our 24/7 support would be happy to assist you via chat or email:
support@eodhistoricaldata.comVisit also: